2m 2m 2m 2m 2m 2m 2m
NEKTAR THERAPEUT (NKTR)
NASDAQ
$66.72+$1.02 (+1.54%)
Price as of Jun 23, 2026 4:10 PM EDT- $2.2BMarket Cap
- 588.68%1-Year Change
- BiotechnologyIndustry
NEKTAR THERAPEUT (NKTR)
$66.72+$1.02 (+1.54%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
OPPENHEIMERFUNDS, INC. | 88.55% | 17.3M | -34 (-0.0002%) | Mar 31, 2019 |
BLACKROCK FUNDING, INC. /DE | 82.35% | 16.1M | +122,236 (+0.76%) | Dec 31, 2024 |
BLACKROCK INC. | 77.56% | 15.2M | +9.3M (+61.21%) | Jun 30, 2024 |
BLACKROCK FUND ADVISORS | 70.84% | 13.8M | +2.9M (+20.75%) | Dec 31, 2016 |
WELLINGTON MANAGEMENT CO LLP | 58.26% | 11.4M | 0 (0.00%) | Dec 31, 2021 |
FMR LLC | 22.02% | 4.3M | +4.2M (+97.65%) | Mar 31, 2026 |
CAMBER CAPITAL MANAGEMENT LP | 20.47% | 4.0M | +250,000 (+6.25%) | Mar 31, 2022 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS) | 183.05% | 35.8M | 0 (0.00%) | Jan 31, 2026 |
VANGUARD SPECIALIZED FUNDS | 58.26% | 11.4M | 0 (0.00%) | Jan 31, 2026 |
VANGUARD INDEX FUNDS | 42.92% | 8.4M | 0 (0.00%) | Mar 31, 2026 |
FIRST TRUST EXCHANGE-TRADED FUND | 39.86% | 7.8M | 0 (0.00%) | Mar 31, 2026 |
MUTUAL FUND SERIES TRUST | 34.03% | 6.7M | 0 (0.00%) | Mar 31, 2026 |
PRIMECAP Odyssey Funds | 22.52% | 4.4M | 0 (0.00%) | Jan 31, 2026 |
VANGUARD HORIZON FUNDS | 11.67% | 2.3M | 0 (0.00%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions2.2B (64.54%)
- Mutual Funds1.2B (34.82%)
- Insiders22.0M (0.64%)
- Other0 (0.00%)
Insider Transactions
- 0.64% (22.0M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 3Number of InsiderSelling (last 12 months)
- $42.2MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
ROBIN HOWARD W President & CEO | Sell | Jun 17, 2026 | $334,455.00 | 5,500 | $60.81 | 59,545 |
ROBIN HOWARD W President & CEO | Sell | Jun 17, 2026 | $277,425.00 | 4,500 | $61.65 | 55,045 |
ROBIN HOWARD W President & CEO | Sell | Jun 16, 2026 | $318,020.91 | 5,303 | $59.97 | 69,742 |
ROBIN HOWARD W President & CEO | Sell | Jun 16, 2026 | $285,154.87 | 4,697 | $60.71 | 65,045 |
Zalevsky Jonathan Chief R&D Officer | Sell | Jun 15, 2026 | $336,211.98 | 5,538 | $60.71 | 15,437 |
ROBIN HOWARD W President & CEO | Sell | Feb 18, 2026 | $30,879.00 | 423 | $73.00 | 75,489 |
Zalevsky Jonathan Chief R&D Officer | Sell | Jan 20, 2026 | $137,935.89 | 3,867 | $35.67 | 21,354 |
Zalevsky Jonathan Chief R&D Officer | Award | Dec 22, 2025 | $0.00 | 25,000 | $0.00 | 25,000 |
Zalevsky Jonathan Chief R&D Officer | Award | Dec 22, 2025 | $0.00 | 6,250 | $0.00 | 25,221 |
Zalevsky Jonathan Chief R&D Officer | Sell | Nov 25, 2025 | $62,801.96 | 1,157 | $54.28 | 18,971 |
ROBIN HOWARD W President & CEO | Sell | Nov 25, 2025 | $119,795.96 | 2,207 | $54.28 | 54,245 |
Wilson Mark Andrew Chief Legal Officer | Sell | Nov 25, 2025 | $34,196.40 | 630 | $54.28 | 21,585 |
ROBIN HOWARD W President & CEO | Award | Nov 21, 2025 | $0.00 | 12,170 | $0.00 | 12,170 |
Zalevsky Jonathan Chief R&D Officer | Award | Nov 21, 2025 | $0.00 | 4,766 | $0.00 | 4,766 |
ROBIN HOWARD W President & CEO | Award | Nov 21, 2025 | $0.00 | 7,110 | $0.00 | 56,452 |
Wilson Mark Andrew Chief Legal Officer | Award | Nov 21, 2025 | $0.00 | 3,400 | $0.00 | 3,400 |
Zalevsky Jonathan Chief R&D Officer | Award | Nov 21, 2025 | $0.00 | 2,666 | $0.00 | 20,128 |
Wilson Mark Andrew Chief Legal Officer | Award | Nov 21, 2025 | $0.00 | 1,903 | $0.00 | 22,215 |
WHITFIELD ROY A | Award | Sep 30, 2025 | $0.00 | 8,000 | $0.00 | 8,000 |
Ajer Jeffrey Robert | Award | Sep 30, 2025 | $0.00 | 8,000 | $0.00 | 8,000 |
CHESS ROBERT | Award | Sep 30, 2025 | $0.00 | 8,000 | $0.00 | 8,000 |
ROBIN HOWARD W President & CEO | Sell | Sep 09, 2025 | $94,836.00 | 2,100 | $45.16 | 53,908 |
ROBIN HOWARD W President & CEO | Sell | Sep 09, 2025 | $55,692.00 | 1,200 | $46.41 | 52,708 |
ROBIN HOWARD W President & CEO | Sell | Sep 09, 2025 | $102,388.44 | 2,156 | $47.49 | 50,552 |
ROBIN HOWARD W President & CEO | Sell | Sep 09, 2025 | $58,297.80 | 1,210 | $48.18 | 49,342 |
Zalevsky Jonathan Chief R&D Officer | Sell | Sep 04, 2025 | $25,716.99 | 793 | $32.43 | 18,390 |
Zalevsky Jonathan Chief R&D Officer | Sell | Sep 04, 2025 | $14,515.20 | 432 | $33.60 | 17,958 |
Zalevsky Jonathan Chief R&D Officer | Sell | Sep 04, 2025 | $6,503.49 | 189 | $34.41 | 17,769 |
Zalevsky Jonathan Chief R&D Officer | Sell | Sep 04, 2025 | $10,956.83 | 307 | $35.69 | 17,462 |
Zalevsky Jonathan Chief R&D Officer | Sell | Sep 02, 2025 | $14,598.50 | 485 | $30.10 | 19,183 |